Trial shows alcohol-mimicking medication can give laryngeal dystonia patients back their voice
KEY TAKEAWAYS
Researchers from Mass Eye and Ear conducted a clinical trial of sodium oxybate, an oral medication used to treat narcolepsy, for the treatment of laryngeal dystonia, an often-debilitating neurological condition that impacts speech.
Trial was borne out of patient reports of symptom improvements after consuming alcohol.
A single dose of sodium oxybate significantly improved symptoms for alcohol-responsive patients, with effects lasting up to 5 hours.
The trial involved participants from across the U.S., U.K., and Canada and brings hope to the laryngeal dystonia community, who currently lack effective oral ...









